![](/img/cover-not-exists.png)
P-184 * nab-Paclitaxel (nab-P) plus gemcitabine (Gem) for patients with advanced pancreatic cancer who have cholestatic hyperbilirubinemia (CH) secondary to bile duct obstruction: a phase I safety and pharmacokinetics study
Riess, H., Kunzmann, V., Philip, P., Seufferlein, T., McGovern, D., Chen, P., Romano, A., Ramanathan, R.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.184
Date:
June, 2015
File:
PDF, 61 KB
english, 2015